Pharmerica Corp (PMC) 26.61 $PMC PharMerica Ris
Post# of 273249
Posted On: 09/07/2016 1:15:23 AM
Pharmerica Corp (PMC) 26.61 $PMC
PharMerica Rises 14.24% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Aug 24, 2:02PM CDT
PharMerica (NYSE
MC) traded in a range yesterday that spanned from a low of $22.46 to a high of $26.75. Yesterday, the shares gained 14.2%, which took the trading range above the 3-day high of $23.25 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PMC: 26.61 (+0.66)
PharMerica Joins DC-Based Senior Care Pharmacy Coalition (SCPC) Citing Need for Effective, Focused Advocacy on Long Term Care (LTC) Pharmacy Issues
PR Newswire - Tue Aug 16, 10:56AM CDT
The Senior Care Pharmacy Coalition (SCPC), the only national organization dedicated exclusively to the highly-specific legislative and regulatory interests of America's growing and dynamic long term care (LTC) pharmacy sector and the patients they serve, today welcomed as a new member PharMerica Corporation (NYSE: PMC), a major national provider of LTC pharmacy services. LTC pharmacies provide consultative pharmacy services and medications to seniors in skilled nursing and residential care settings.
PMC: 26.61 (+0.66)
PharMerica (PMC) Q2 Earnings in Line, Revenues Beat
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 7:16AM CDT
PharMerica reported second-quarter 2016 adjusted earnings of 47 cents per share.
PMC: 26.61 (+0.66), BABY: 42.11 (+1.47), MASI: 59.54 (-0.36), HSKA: 55.56 (+3.07)
The Zacks Analyst Blog Highlights: Intrexon, PharMerica, Surgery Partners, Civitas Solutions and Healthways
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 8:30AM CDT
The Zacks Analyst Blog Highlights: Intrexon, PharMerica, Surgery Partners, Civitas Solutions and Healthways
SGRY: 20.74 (+0.70), PMC: 26.61 (+0.66), CIVI: 18.37 (+0.03), HWAY: 25.34 (+0.38), XON: 26.00 (+0.67)
PharMerica Corporation Announces Planned Retirement of Chief Financial Officer David W. Froesel, Jr.
BusinessWire - Tue Aug 09, 7:01AM CDT
PharMerica Corporation (NYSE: PMC), a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, today announced that David W. Froesel Jr., Executive Vice President, Chief Financial Officer and Treasurer, intends to retire from the Company. Mr. Froesel will continue as Chief Financial Officer through the end of September 2016 to ensure a seamless transition. PharMerica has initiated a comprehensive search process to identify Mr. Froesel's successor and has engaged a nationally recognized executive search firm.
PMC: 26.61 (+0.66)
PharMerica Reports Second Quarter 2016 Results
BusinessWire - Tue Aug 09, 7:00AM CDT
--Reaffirms Annual 2016 Guidance
PMC: 26.61 (+0.66)
Healthcare Stocks' Aug 9 Earnings Roster: XON, PMC & More
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 8:09AM CDT
Here, we take a look at five healthcare stocks scheduled to report their quarterly figures on Aug 9.
SGRY: 20.74 (+0.70), PMC: 26.61 (+0.66), CIVI: 18.37 (+0.03), XON: 26.00 (+0.67), HWAY: 25.34 (+0.38)
Zacks.com featured highlights: Dean Foods, PharMerica, Tower International, Ford Motor and Carnival
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 8:30AM CDT
Zacks.com featured highlights: Dean Foods, PharMerica, Tower International, Ford Motor and Carnival
PMC: 26.61 (+0.66), F: 12.67 (+0.17), CUK: 46.42 (-0.49), DF: 17.27 (+0.02), TOWR: 24.44 (+0.04)
5 Medical Stocks with Incredibly Low PEG Ratios
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 10:08AM CDT
Medical is attractive for value investors due to its resiliency during volatile phases on the back of strong fundamentals of the constituent companies.
PMC: 26.61 (+0.66), ESRX: 72.72 (+0.18), AIRM: 35.55 (-0.24), PRAH: 49.62 (-0.76), MGLN: 54.68 (-1.07)
5 Low Price-to-Cash-Flow Stocks with High Return Prospects
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 7:46AM CDT
Value style is generally considered one of the best practices when it comes to stock picking. For this, we would suggest considering Price to Cash Flow (or P/CF) ratio as one of the key metrics.
PMC: 26.61 (+0.66), F: 12.67 (+0.17), CUK: 46.42 (-0.49), DF: 17.27 (+0.02), TOWR: 24.44 (+0.04)
Zacks.com featured highlights: United Natural Foods, Weight Watchers International, PharMerica, Boardwalk Pipeline Partners and Neogenomics
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 8:30AM CDT
Zacks.com featured highlights: United Natural Foods, Weight Watchers International, PharMerica, Boardwalk Pipeline Partners and Neogenomics
PMC: 26.61 (+0.66), UNFI: 45.80 (+0.01), NEO: 7.88 (-0.12), BWP: 16.91 (+0.32), WTW: 10.28 (+0.02)
Bet on These 5 Stocks with Upgraded Broker Ratings
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 8:14AM CDT
After thorough research, brokers decide to rate that particular company's stock. Naturally, when an analyst upgrades a stock, you can easily rely on it.
PMC: 26.61 (+0.66), UNFI: 45.80 (+0.01), NEO: 7.88 (-0.12), BWP: 16.91 (+0.32), WTW: 10.28 (+0.02)
Why the Earnings Streak Will Continue for PharMerica (PMC)
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 7:40AM CDT
PharMerica (PMC) currently has a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.
PMC: 26.61 (+0.66)
Forget Growth; Focus on Earnings Beat with These 4 Stocks
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 8:20AM CDT
Your search for stocks with the potential of positive earnings surprise ends here.
PMC: 26.61 (+0.66), PLAY: 46.27 (-0.33), BMY: 56.96 (+0.61), TEGP: 23.62 (+0.36)
5 Best Low-Beta Stocks to Buy as Volatility Hits a 3-Month High
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 9:20AM CDT
A measure of expected volatility soared to its highest level in three months, the latest sign of increasing fears among investors.
PMC: 26.61 (+0.66), WPT: 15.27 (-0.15), PLAY: 46.27 (-0.33), DF: 17.27 (+0.02), MGLN: 54.68 (-1.07)
Chemed Posts Balanced Growth amid Coding Change Issues
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 5:42AM CDT
On Jun 7, 2016, we issued an updated research report on Chemed Corporation (CHE).
CHE: 137.48 (+0.14), PMC: 26.61 (+0.66), LHCG: 35.46 (-0.47), HLS: 40.81 (unch)
The Zacks Analyst Blog Highlights: JinkoSolar Holding, Carnival, PharMerica, Air Methods and Tower International
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 8:30AM CDT
The Zacks Analyst Blog Highlights: JinkoSolar Holding, Carnival, PharMerica, Air Methods and Tower International
PMC: 26.61 (+0.66), AIRM: 35.55 (-0.24), CUK: 46.42 (-0.49), TOWR: 24.44 (+0.04), JKS: 18.53 (+0.09)
Surging Earnings Estimates Signal Good News for PharMerica (PMC)
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 7:42AM CDT
Positive earnings estimate revisions, coupled with impressive Zacks Rank has made PharMerica (PMC) an interesting choice for the investors.
PMC: 26.61 (+0.66)
5 Stocks with Impressive Price-to-Cash-Flow Ratio
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 12:13PM CDT
The strategy is quite simple - find stocks that are trading below their inherent worth.
PMC: 26.61 (+0.66), AIRM: 35.55 (-0.24), CUK: 46.42 (-0.49), TOWR: 24.44 (+0.04), JKS: 18.53 (+0.09)
DaVita to Expand in Orlando with Family Health Care Buyout
Zacks Equity Research - Zacks Investment Research - Mon May 23, 3:07PM CDT
DaVita Healthcare Partners (DVA) has entered into a definitive agreement to acquire Family Health Care of Central Florida to expand its presence in Orlando metro area.
PMC: 26.61 (+0.66), AFAM: 36.74 (+0.11), DVA: 64.06 (-0.72), HLS: 40.81 (unch)
PharMerica Rises 14.24% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Aug 24, 2:02PM CDT
PharMerica (NYSE
MC) traded in a range yesterday that spanned from a low of $22.46 to a high of $26.75. Yesterday, the shares gained 14.2%, which took the trading range above the 3-day high of $23.25 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. PMC: 26.61 (+0.66)
PharMerica Joins DC-Based Senior Care Pharmacy Coalition (SCPC) Citing Need for Effective, Focused Advocacy on Long Term Care (LTC) Pharmacy Issues
PR Newswire - Tue Aug 16, 10:56AM CDT
The Senior Care Pharmacy Coalition (SCPC), the only national organization dedicated exclusively to the highly-specific legislative and regulatory interests of America's growing and dynamic long term care (LTC) pharmacy sector and the patients they serve, today welcomed as a new member PharMerica Corporation (NYSE: PMC), a major national provider of LTC pharmacy services. LTC pharmacies provide consultative pharmacy services and medications to seniors in skilled nursing and residential care settings.
PMC: 26.61 (+0.66)
PharMerica (PMC) Q2 Earnings in Line, Revenues Beat
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 7:16AM CDT
PharMerica reported second-quarter 2016 adjusted earnings of 47 cents per share.
PMC: 26.61 (+0.66), BABY: 42.11 (+1.47), MASI: 59.54 (-0.36), HSKA: 55.56 (+3.07)
The Zacks Analyst Blog Highlights: Intrexon, PharMerica, Surgery Partners, Civitas Solutions and Healthways
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 8:30AM CDT
The Zacks Analyst Blog Highlights: Intrexon, PharMerica, Surgery Partners, Civitas Solutions and Healthways
SGRY: 20.74 (+0.70), PMC: 26.61 (+0.66), CIVI: 18.37 (+0.03), HWAY: 25.34 (+0.38), XON: 26.00 (+0.67)
PharMerica Corporation Announces Planned Retirement of Chief Financial Officer David W. Froesel, Jr.
BusinessWire - Tue Aug 09, 7:01AM CDT
PharMerica Corporation (NYSE: PMC), a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, today announced that David W. Froesel Jr., Executive Vice President, Chief Financial Officer and Treasurer, intends to retire from the Company. Mr. Froesel will continue as Chief Financial Officer through the end of September 2016 to ensure a seamless transition. PharMerica has initiated a comprehensive search process to identify Mr. Froesel's successor and has engaged a nationally recognized executive search firm.
PMC: 26.61 (+0.66)
PharMerica Reports Second Quarter 2016 Results
BusinessWire - Tue Aug 09, 7:00AM CDT
--Reaffirms Annual 2016 Guidance
PMC: 26.61 (+0.66)
Healthcare Stocks' Aug 9 Earnings Roster: XON, PMC & More
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 8:09AM CDT
Here, we take a look at five healthcare stocks scheduled to report their quarterly figures on Aug 9.
SGRY: 20.74 (+0.70), PMC: 26.61 (+0.66), CIVI: 18.37 (+0.03), XON: 26.00 (+0.67), HWAY: 25.34 (+0.38)
Zacks.com featured highlights: Dean Foods, PharMerica, Tower International, Ford Motor and Carnival
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 8:30AM CDT
Zacks.com featured highlights: Dean Foods, PharMerica, Tower International, Ford Motor and Carnival
PMC: 26.61 (+0.66), F: 12.67 (+0.17), CUK: 46.42 (-0.49), DF: 17.27 (+0.02), TOWR: 24.44 (+0.04)
5 Medical Stocks with Incredibly Low PEG Ratios
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 10:08AM CDT
Medical is attractive for value investors due to its resiliency during volatile phases on the back of strong fundamentals of the constituent companies.
PMC: 26.61 (+0.66), ESRX: 72.72 (+0.18), AIRM: 35.55 (-0.24), PRAH: 49.62 (-0.76), MGLN: 54.68 (-1.07)
5 Low Price-to-Cash-Flow Stocks with High Return Prospects
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 7:46AM CDT
Value style is generally considered one of the best practices when it comes to stock picking. For this, we would suggest considering Price to Cash Flow (or P/CF) ratio as one of the key metrics.
PMC: 26.61 (+0.66), F: 12.67 (+0.17), CUK: 46.42 (-0.49), DF: 17.27 (+0.02), TOWR: 24.44 (+0.04)
Zacks.com featured highlights: United Natural Foods, Weight Watchers International, PharMerica, Boardwalk Pipeline Partners and Neogenomics
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 8:30AM CDT
Zacks.com featured highlights: United Natural Foods, Weight Watchers International, PharMerica, Boardwalk Pipeline Partners and Neogenomics
PMC: 26.61 (+0.66), UNFI: 45.80 (+0.01), NEO: 7.88 (-0.12), BWP: 16.91 (+0.32), WTW: 10.28 (+0.02)
Bet on These 5 Stocks with Upgraded Broker Ratings
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 8:14AM CDT
After thorough research, brokers decide to rate that particular company's stock. Naturally, when an analyst upgrades a stock, you can easily rely on it.
PMC: 26.61 (+0.66), UNFI: 45.80 (+0.01), NEO: 7.88 (-0.12), BWP: 16.91 (+0.32), WTW: 10.28 (+0.02)
Why the Earnings Streak Will Continue for PharMerica (PMC)
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 7:40AM CDT
PharMerica (PMC) currently has a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.
PMC: 26.61 (+0.66)
Forget Growth; Focus on Earnings Beat with These 4 Stocks
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 8:20AM CDT
Your search for stocks with the potential of positive earnings surprise ends here.
PMC: 26.61 (+0.66), PLAY: 46.27 (-0.33), BMY: 56.96 (+0.61), TEGP: 23.62 (+0.36)
5 Best Low-Beta Stocks to Buy as Volatility Hits a 3-Month High
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 9:20AM CDT
A measure of expected volatility soared to its highest level in three months, the latest sign of increasing fears among investors.
PMC: 26.61 (+0.66), WPT: 15.27 (-0.15), PLAY: 46.27 (-0.33), DF: 17.27 (+0.02), MGLN: 54.68 (-1.07)
Chemed Posts Balanced Growth amid Coding Change Issues
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 5:42AM CDT
On Jun 7, 2016, we issued an updated research report on Chemed Corporation (CHE).
CHE: 137.48 (+0.14), PMC: 26.61 (+0.66), LHCG: 35.46 (-0.47), HLS: 40.81 (unch)
The Zacks Analyst Blog Highlights: JinkoSolar Holding, Carnival, PharMerica, Air Methods and Tower International
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 8:30AM CDT
The Zacks Analyst Blog Highlights: JinkoSolar Holding, Carnival, PharMerica, Air Methods and Tower International
PMC: 26.61 (+0.66), AIRM: 35.55 (-0.24), CUK: 46.42 (-0.49), TOWR: 24.44 (+0.04), JKS: 18.53 (+0.09)
Surging Earnings Estimates Signal Good News for PharMerica (PMC)
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 7:42AM CDT
Positive earnings estimate revisions, coupled with impressive Zacks Rank has made PharMerica (PMC) an interesting choice for the investors.
PMC: 26.61 (+0.66)
5 Stocks with Impressive Price-to-Cash-Flow Ratio
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 12:13PM CDT
The strategy is quite simple - find stocks that are trading below their inherent worth.
PMC: 26.61 (+0.66), AIRM: 35.55 (-0.24), CUK: 46.42 (-0.49), TOWR: 24.44 (+0.04), JKS: 18.53 (+0.09)
DaVita to Expand in Orlando with Family Health Care Buyout
Zacks Equity Research - Zacks Investment Research - Mon May 23, 3:07PM CDT
DaVita Healthcare Partners (DVA) has entered into a definitive agreement to acquire Family Health Care of Central Florida to expand its presence in Orlando metro area.
PMC: 26.61 (+0.66), AFAM: 36.74 (+0.11), DVA: 64.06 (-0.72), HLS: 40.81 (unch)
(0)
(0)Scroll down for more posts ▼